Dr. Pantuck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UCLA Medical Center
10833 LeConte Ave, 66-128 CHS
Los Angeles, CA 90095Phone+1 310-206-2436Fax+1 310-206-2436- Is this information wrong?
Education & Training
- Rutgers Robert Wood Johnson Medical SchoolResidency, Urology, 1995 - 1999
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 1993 - 1995
- Rutgers Robert Wood Johnson Medical SchoolClass of 1993
Certifications & Licensure
- CA State Medical License 1999 - 2025
- FL State Medical License 2017 - 2019
- NJ State Medical License 1995 - 1999
- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Biological Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2002 Mar 01
- Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer Start of enrollment: 2004 Nov 30
- Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer Start of enrollment: 2004 May 01
- Join now to see all
Publications & Presentations
PubMed
- Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.Cedric Lebacle, Aydin Pooli, Brian Shuch, Nagesh Rao, Karim Chamie, Nils Kroeger, Izak Faiena, Sandy Liu, Erika L Wood, Arie Belldegrun, Alexandra Drakaki, Allan J Pan...> ;Cancer Investigation. 2024 Jan 1
- 1 citationsCD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma.Rong Rong Huang, Zhengshan Chen, Nils Kroeger, Allan Pantuck, Jonathan Said, Harriet M Kluger, Brian Shuch, Huihui Ye> ;Clinical Genitourinary Cancer. 2024 Apr 1
- 1 citationsDo Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma.Gavin Hui, Dimitrios Stefanoudakis, Yuliya Zektser, Dayna Jill Isaacs, Christopher Hannigan, Allan J Pantuck, Alexandra Drakaki> ;Current Oncology. 2023 Aug 4
- Join now to see all
Other
- Surveillance for metastatic disease after nephrectomy for renal cell carcinomaPantuck AJ, Shuch B, Klatte T
http://www.uptodate.com/contents/surveillance-for-metastatic-disease-after-nephrectomy-for-renal-cel
UpToDate, Wolters Kluwer Health - 2012-08-16
Authored Content
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
Press Mentions
- Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063March 29th, 2023
- Abraham Verghese MD, Noted Stanford Physician and Recipient of the National Humanities Medal at the White House from Former President Obama, Appointed to the Board of Directors of Athos TherapeuticsMay 18th, 2022
- UCLA Researchers to Present on Latest Research and Clinical Advancements at American Urological Association Annual MeetingAugust 26th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Ronald Reagan UCLA Medical CenterLos Angeles, California
- UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: